SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

4.550 -0.170 (-3.60%)

Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

September 16, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer

September 11, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

September 06, 2024

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

September 06, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Is SciSparc (SPRC) Stock Up 94% Today? ↗

August 15, 2024

SciSparc stock is up on Thursday with heavy trading of SPRC shares after it provided an update on its merger with AutoMax.

Via InvestorPlace

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

August 29, 2024

From SciSparc Ltd

Via GlobeNewswire

Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

August 29, 2024

Via Benzinga

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

August 28, 2024

From SciSparc Ltd

Via GlobeNewswire

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

August 26, 2024

Via Benzinga

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

August 23, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

August 22, 2024

From SciSparc Ltd

Via GlobeNewswire

Autism CBD Trial On Children Advances As Israeli Company Enrolls First Five Patients ↗

August 20, 2024

SciSparc Ltd. (NASDAQ: SPRC) announced on Tuesday that the first five patients have been enrolled and dosed into its ongoing clinical trial in children suffering from autism spectrum disorder (ASD) at...

Via Benzinga

SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment

August 19, 2024

From SciSparc Ltd

Via GlobeNewswire

Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy ↗

August 19, 2024

SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties.

Via Benzinga

Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

August 19, 2024

Via Benzinga

SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million

August 16, 2024

From SciSparc Ltd

Via GlobeNewswire

Nasdaq Jumps Over 2%; Walmart Earnings Top Views ↗

August 15, 2024

Via Benzinga

Dow Surges Over 500 Points; US Retail Sales Rise In July ↗

August 15, 2024

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 15, 2024

Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today!

Via InvestorPlace

Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2024

Via Benzinga

SciSparc Updates Regarding the Status of the AutoMax Merger

August 14, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

August 06, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

July 22, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

July 17, 2024

From SciSparc Ltd

Via GlobeNewswire

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 16, 2024

Via Benzinga

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

July 16, 2024

From SciSparc Ltd

Via GlobeNewswire

Mizuho Just Issued a Warning on Palantir (PLTR) Stock ↗

July 16, 2024

Palantir Technologies stock is down on Tuesday after shares of PLTR were hit with a downgrade from Mizuho analysts this morning.

Via InvestorPlace

Why Is SciSparc (SPRC) Stock Up 25% Today? ↗

July 16, 2024

SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment.

Via InvestorPlace

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 16, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!

Via InvestorPlace

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

July 16, 2024

From SciSparc Ltd

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.